Navigation Links
Neogen Names Quinlan as CFO
Date:1/6/2011

LANSING, Mich., Jan. 6, 2011 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has named Steven J. Quinlan as the Company's chief financial officer to replace the retiring Richard Current. Current will immediately relinquish his responsibilities as CFO, but will remain with Neogen through the end of the fiscal year, May 31.

Quinlan joins Neogen following 19 years at Detrex Corporation, the last eight as CFO, vice president of finance, and treasurer. In the position, he was responsible for all of Detrex's finance, accounting, and reporting activities. Detrex is a publicly held diversified manufacturer of PVC and CPVC pipe, duct and shapes, and specialty chemicals including additives for industrial petroleum products and high purity hydrochloric acid.

"While we understand the challenge of trying to replace Rick's extensive skills and experience, we are very pleased to have found someone of Mr. Quinlan's caliber to fill the position," said Lon Bohannon, Neogen's president. "His many years as a CFO, combined with his experience as a CPA and knowledge of SEC procedures and regulations, will serve Neogen well as we go forward."

After graduating from the University of Michigan with a degree in business administration, Quinlan earned his CPA while working as an auditor at Price Waterhouse for more than four years; he also served in various financial positions for Ford Motor Company. He joined Detrex as a division controller after completing his MBA at Wayne State University in 1991.  

Current assumed the position of Neogen's CFO in November 1999, and has helped drive the company's consistent earnings growth and heightened stature in the investment community. He will remain an employee of Neogen through the end of the current fiscal year to ensure an orderly transition for the role of CFO.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Reports 33% Increase in Net Income
2. Neogen Corporation Announces 2nd Quarter Results Conference Call
3. Neogens Rapid Test for Salmonella enteritidis Receives AOAC Approval
4. NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010
5. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
6. Neogen Corporation Announces 3rd Quarter Results Conference Call
7. Neogen Reports 18% Increase in Net Income
8. Richard T. Crowder Joins Neogens Board of Directors
9. Neogen Announces 3 for-2 Stock Split
10. Neogen to Ring NASDAQs Closing Bell
11. NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):